Adiponectin attenuates human eosinophil adhesion and chemotaxis: Implications in allergic inflammation

Journal of Asthma

Volumn 50, Issue 8, 2013, Pages 828-835

  Yamamoto, Rie ^a   Ueki, Shigeharu ^a   Moritoki, Yuki ^a   Kobayashi, Yoshiki ^a   Oyamada, Hajime ^a   Konno, Yasunori ^a   Tamaki, Mami ^a   Itoga, Masamichi ^a   Takeda, Masahide ^a   Ito, Wataru ^a   Chihara, Junichi ^a  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adhesion; Adiponectin; Asthma; Chemotaxis; Eosinophils; Obesity

Indexed keywords

ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; CHEMOKINE RECEPTOR CCR3; LIPOCORTIN 5; PROPIDIUM IODIDE;

ALLERGIC ASTHMA; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL SURVIVAL; CELL VIABILITY; CHEMOTAXIS; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OBESITY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84884233549     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2013.816725     Document Type: Article

References (42)

1. Taylor B, Mannino D, Brown C, Crocker D, Twum-Baah N, Holguin F. Body mass index and asthma severity in the National Asthma Survey. Thorax 2008;63:14-20
2. Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: A meta-Analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007;175:661-666
3. Chinn S, Jarvis D, Burney P. Relation of bronchial responsiveness to body mass index in the ECRHS. European Community Respiratory Health Survey. Thorax 2002;57:1028-1033
4. Litonjua AA, Sparrow D, Celedon JC, DeMolles D, Weiss ST. Association of body mass index with the development of methacholine airway hyperresponsiveness in men: The Normative Aging Study. Thorax 2002;57:581-585
5. Sood A, Verhulst SJ, Varma A, Eagleton LE, Henkle JQ, Hopkins-Price P. Association of excess weight and degree of airway responsiveness in asthmatics and non-Asthmatics. J Asthma 2006; 43:447-452
6. Boulet LP, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med 2007;101:2240-2247
7. Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM. Influence of body mass index on the response to asthma controller agents. Eur Respir J 2006;27:495-503
8. Stenius-Aarniala B, Poussa T, Kvarnstrom J, Gronlund EL, Ylikahri M, Mustajoki P. Immediate and long term effects of weight reduction in obese people with asthma: Randomised controlled study. BMJ 2000;320:827-832
9. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911-919 (quiz 20
10. Takeda M, Ueki S, Kato H, Konno Y, Chihara M, Itoga M, Kobayashi Y, et al. Obesity and eosinophilic inflammation: Does leptin play a role. Int Arch Allergy Immunol 2012;158:87-91
11. Okamoto Y, Folco EJ, Minami M, Wara AK, Feinberg MW, Sukhova GK, Colvin RA, et al. Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. Circ Res 2008;102: 218-225
12. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, Okada-Iwabu M, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 2007;13:332-339
13. Gavrila A, Chan JL, Yiannakouris N, Kontogianni M, Miller LC, Orlova C, Mantzoros CS. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: Cross-sectional and interventional studies. J Clin Endocrinol Metab 2003;88:4823-4831
14. Tsai JS, Chen CY, Chen YL, Chuang LM. Rosiglitazone inhibits monocyte/macrophage adhesion through de novo adiponectin production in human monocytes. J Cell Biochem 2010;110: 1410-1419
15. Sood A, Qualls C, Schuyler M, Thyagarajan B, Steffes MW, Smith LJ, Jacobs DR. Low serum adiponectin predicts future risk for asthma in women. Am J Respir Crit Care Med 2012;186: 41-47
16. Hsueh KC, Lin YJ, Lin HC, Lin CY. Serum leptin and adiponectin levels correlate with severity of allergic rhinitis. Pediatr Allergy Immunol 2010;21:e155-159
17. Shore SA, Terry RD, Flynt L, Xu A, Hug C. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol 2006;118:389-395
18. Medoff BD, Okamoto Y, Leyton P, Weng M, Sandall BP, Raher MJ, Kihara S, et al. Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. Am J Respir Cell Mol Biol 2009;41:397-406
19. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 2006;24:147-174
20. Kita H. Eosinophils: Multifaceted biological properties and roles in health and disease. Immunol Rev. 2011;242:161-177
21. Kato H, Ueki S, Kamada R, Kihara J, Yamauchi Y, Suzuki T, Takeda M, et al. Leptin has a priming effect on eotaxin-induced human eosinophil chemotaxis. Int Arch Allergy Immunol 2011; 155:335-344
22. Ueki S, Kihara J, Kato H, Ito W, Takeda M, Kobayashi Y, Kayaba H, et al. Soluble vascular cell adhesion molecule-1 induces human eosinophil migration. Allergy 2009;64:718-724
23. Ueki S, Mahemuti G, Oyamada H, Kato H, Kihara J, Tanabe M, Ito W, et al. Retinoic acids are potent inhibitors of spontaneous human eosinophil apoptosis. J Immunol. 2008;181:7689-7698
24. Hirasawa H, Chiba T, Ueki S, Kamada Y, Ito W, Takeda M, Fujita M, et al. The synthetic PPARgamma agonist troglitazone inhibits eotaxin-enhanced eosinophil adhesion to ICAM-1-coated plates. Int Arch Allergy Immunol 2008;146:11-15
25. Tanigai T, Ueki S, Kihara J, Kamada R, Yamauchi Y, Sokal A, Takeda M, et al. Docosahexaenoic acid exerts anti-inflammatory action on human eosinophils through Peroxisome Proliferator-Activated Receptor-independent mechanisms. Int Arch Allergy Immunol 2012;158:375-386
26. Ito W, Chiba T, Kanehiro A, Kato H, Yamaguchi K, Ueki S, Kayaba H, et al. Hepatocyte growth factor attenuates eotaxin and PGD2-induced chemotaxis of human eosinophils. Allergy 2007;62: 415-422
27. Pang TT, Narendran P. The distribution of adiponectin receptors on human peripheral blood mononuclear cells. Ann N Y Acad Sci 2008;1150:143-145
28. Kollias A, Tsiotra PC, Ikonomidis I, Maratou E, Mitrou P, Kyriazi E, Boutati E, et al. Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease. Cardiovasc Diabetol 2011; 10:14.
29. Nitta N, Tsuchiya T, Yamauchi A, Tamatani T, Kanegasaki S. Quantitative analysis of eosinophil chemotaxis tracked using a novel optical device-TAXIScan. J Immunol Methods 2007;320: 155-163
30. Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK, Chawla A, et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011;332:243-247
31. Mahadev K, Wu X, Donnelly S, Ouedraogo R, Eckhart AD, Goldstein BJ. Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells. Cardiovasc Res 2008;78:376384
32. Saito N, Yamada Y, Sannohe S, Honda K, Adachi T, Kayaba H, Chihara J, et al. Possible involvement of C-C chemokines in functional augmentation of adhesion molecules in asthmatic patients. Lung 2002;180:251-263
33. Manes S, Gomez-Mouton C, Lacalle RA, Jimenez-Baranda S, Mira E, Martinez AC. Mastering time and space: Immune cell polarization and chemotaxis. Semin Immunol 2005;17:77-86
34. Tenscher K, Metzner B, Schopf E, Norgauer J, Czech W. Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. Blood 1996;88: 3195-3199
35. Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang J, Kassam N, Smith H, et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996;97:604-612
36. Cottam DR, Schaefer PA, Shaftan GW, Velcu L, Angus LD. Effect of surgically-induced weight loss on leukocyte indicators of chronic inflammation in morbid obesity. Obes Surg 2002;12:335-342
37. Shim WS, Kim HJ, Kang ES, Ahn CW, Lim SK, Lee HC, Cha BS. The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients. Diabetes Res Clin Pract 2006;73:284-291
38. van Veen IH, Ten Brinke A, Sterk PJ, Rabe KF, Bel EH. Airway inflammation in obese and nonobese patients with difficult-To-Treat asthma. Allergy 2008;63:570-574
39. Calixto MC, Lintomen L, Schenka A, Saad MJ, Zanesco A, Antunes E. Obesity enhances eosinophilic inflammation in a murine model of allergic asthma. Br J Pharmacol 2010;159: 617-625
40. Shore SA. Obesity, airway hyperresponsiveness, and inflammation. J Appl Physiol 2010;108:735-743
41. Richards DB, Bareille P, Lindo EL, Quinn D, Farrow SN. Treatment with a peroxisomal proliferator activated receptor gamma agonist has a modest effect in the allergen challenge model in asthma: A randomised controlled trial. Respir Med 2010; 104:668-674
42. Spears M, Donnelly I, Jolly L, Brannigan M, Ito K, McSharry C, Lafferty J, et al. Bronchodilatory effect of the PPAR-gamma agonist rosiglitazone in smokers with asthma. Clin Pharmacol Ther 2009; 86:49-53